Radiopharmaceuticals: New antimicrobial agents

Trends in Biotechnology

Volumn 21, Issue 2, 2003, Pages 70-73

  Lupetti, Antonella ^a,b   Nibbering, Peter H ^a   Welling, Mick M ^a   Pauwels, Ernest K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; FLAMMABILITY; PHARMACOKINETICS;

ANTIMICROBIAL AGENTS;

BIOTECHNOLOGY;

ANTIINFECTIVE AGENT; HISTATIN; INDIUM 111; IODINE 125; LACTOFERRIN; PEPTIDE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UBIQUICIDIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; PEPTIDE;

ANTIBIOTIC THERAPY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG SYNTHESIS; INFECTION; INFLAMMATION; ISOTOPE LABELING; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; REPRODUCIBILITY; REVIEW; SCINTIGRAPHY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0037310843     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(02)00032-X     Document Type: Article

References (35)

1. Moser C., et al. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70:2002;3068-3072.
2. Hancock R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:2001;156-164.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395.
4. Lehrer R.I., Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:2002;96-102.
5. Welling M.M., et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. 102:1998;1583-1590.
6. Steinstraesser L., et al. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob. Agents Chemother. 46:2002;1837-1844.
7. Kisich K.O., et al. Antimycobacterial agent based on mRNA encoding human β-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect. Immun. 69:2001;2692-2699.
8. Linde C.M., et al. In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47:2001;575-580.
9. Cole A.M., et al. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc. Natl Acad. Sci. U.S.A. 99:2002;1813-1818.
10. Lupetti A., et al. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44:2000;3257-3263.
11. Nibbering P.H., et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69:2001;1469-1476.
12. Sharma S., et al. Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob. Agents Chemother. 45:2001;639-640.
13. Singh P.K., et al. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L799-L805.
14. Porro G.A., et al. Direct and indirect bacterial killing functions of neutrophil defensins in lung explants. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L1240-L1247.
15. Lupetti, A. et al. Synergistic activity of the N terminal peptide of human lactoferrin and fluconazole against various Candida species. Antimicrob. Agents Chemother. (in press).
16. Helmerhorst E.J., et al. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274:1999;7286-7291.
17. Helmerhorst E.J., et al. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl Acad. Sci. U.S.A. 98:2001;14637-14642.
18. Lupetti A., et al. Internal thiols and reactive oxygen species in the candidacidal activity exerted by a N-terminal peptide of human lactoferrin. Antimicrob. Agents Chemother. 46:2002;1634-1639.
19. Haught C., et al. Recombinant production and purification of novel antisense antimicrobial peptide in Escherichia coli. Biotechnol. Bioeng. 57:1998;55-61.
20. Hwang S.W., et al. A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli. Mol. Biotechnol. 18:2001;193-198.
21. Kluver E., et al. Chemical synthesis of β-defensins and LEAP-1/hepcidin. J. Pept. Res. 59:2002;241-248.
22. Dawson N.F., et al. Chemical synthesis, characterization and activity of RK-1, a novel α-defensin-related peptide. J. Pept. Sci. 6:2000;19-25.
23. Honigman A., et al. Imaging transgene expression in live animals. Mol. Ther. 4:2001;239-249.
24. Lauf U., et al. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc. Natl Acad. Sci. U.S.A. 99:2002;10446-10451.
25. 99m Tc-labelled peptide-based radiopharmaceuticals: an overview. Nucl. Med. Commun. 20:1999;1093-1112.
26. Blok D., et al. Peptide radiopharmaceuticals in nuclear medicine. Eur. J. Nucl. Med. 26:1999;1511-1519.
27. 4 and stannous chloride. Nucl. Med. Biol. 20:1993;825-833.
28. Vanbilloen H.P., et al. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties. Eur. J. Nucl. Med. 23:1996;40-48.
29. 99m Tc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J. Nucl. Med. 42:2001;788-794.
30. Prangère T., et al. Biodistribution of radiolabelled antimicrobial peptides and rapid detection of infection in rats. Eur. J. Nucl. Med. 29:(Suppl. 1):2002;699.
31. 99m Tc-UBI 29-41 for imaging of bacterial infections. Nucl. Med. Biol. 29:2002;413-422.
32. 99m Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J. Nucl. Med. 43:2002;239-245.
33. Lupetti A., et al. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur. J. Nucl. Med. 29:2002;674-679.
34. van Berkel P.H.C., et al. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat. Biotechnol. 20:2002;484-487.
35. Walther S., et al. Pulmonary dynamics of radiolabelled erythrocytes and leucocytes in early gram-negative sepsis in pigs. Eur. J. Surg. 165:1999;979-985.